Table 3.
Summary of thermal simulation on Model I
| Metric | Inactive γ=121° No vaginal cooling |
Inactive γ=111° No vaginal cooling |
Inactive γ=101° No vaginal cooling |
Inactive γ=111° 35°C vaginal cooling |
Inactive γ=101° 35°C vaginal cooling |
Inactive γ=111° 25°C vaginal cooling |
Inactive γ=101° 25°C vaginal cooling |
|---|---|---|---|---|---|---|---|
| Inactive β | 59° | 69° | 79° | 69° | 79° | 69° | 79° |
| Urethra sparing | 1.2 mm | 1.2 mm | 1.2 mm | 1.2 mm | 1.2 mm | 1.3 mm | 1.3 mm |
| Penetration | 11.3 mm | 11.1 mm | 11.1 mm | 11.1 mm | 10.9 mm | 10.8 mm | 10.6 mm |
| deptha | |||||||
| Heated lengthb | 12.7 mm | 12.7 mm | 12.6 mm | 12.6 mm | 12.5 mm | 12.1 mm | 12.0 mm |
| Heated volume | 1.833 cm3 | 1.746 cm3 | 1.700 cm3 | 1.614 cm3 | 1.521 cm3 | 1.323 cm3 | 1.196 cm3 |
| (>60 EM43°C) | (−7.6%)c | (−10.5%)c | (−24.2%)c | (−29.6%)c | |||
| Coagulated | 1.035 cm3 | 0.993 cm3 | 0.969 cm3 | 0.911 cm3 | 0.856 cm3 | 0.709 cm3 | 0.629 cm3 |
| volume | (−8.3%)c | (−11.6%)c | (−28.6%)c | (−35.1%)c | |||
| (>240 EM43°C) | |||||||
| Max T | 57.8°C | 57.7°C | 57.6°C | 57.4°C | 57.3°C | 56.7°C | 56.4°C |
| Max Vagina T | 47.7°C | 48.6°C | 49.6°C | 47.8°C | 48.5°C | 45.4°C | 46.0°C |
| Max Vagina | 25.2 EM43°C | 43.8 EM43°C | 81.1 EM43°C | 26.3 EM43°C | 40.4 EM43°C | 5.1 EM43°C | 7.5 EM43°C |
| Dose | |||||||
| Max Bone T | 49.7°C | 47.7°C | 45.7°C | 47.6°C | 45.7°C | 47.5°C | 45.5°C |
| Max Bone Dose | 79.4 EM43°C | 22.4 EM43°C | 6.4 EM43°C | 22.1 EM43°C | 6.3 EM43°C | 21.1 EM43°C | 6.0 EM43°C |
| Coverage | 73.4° | 72.6° | 72.1° | 71.1° | 70.6° | 67.0° | 65.7° |
| angles (>60 43°C) |
indicates the maximum penetration (>60 EM43°C) in radial direction
indicates the maximum length of heated zone (>60 EM43°C) along the applicator
denotes the heated volume reduction compared to the same applicator configurations without vaginal cooling